Nox Activator 1 | Zendy

Xi-Lin Niu | Zendy; Nageswara R. Madamanchi | Zendy; Aleksandr E. Vendrov | Zendy; Igor Tchivilev | Zendy; Mauricio Rojas | Zendy; Chaitanya Madamanchi | Zendy; Ralf P. Brandes | Zendy; Karl-Heinz Krause | Zendy; Julia Humphries | Zendy; Alberto Smith | Zendy; K G Burnand | Zendy; Marschall S. Runge | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nox Activator 1

Author(s) -

Xi-Lin Niu,

Nageswara R. Madamanchi,

Aleksandr E. Vendrov,

Igor Tchivilev,

Mauricio Rojas,

Chaitanya Madamanchi,

Ralf P. Brandes,

Karl-Heinz Krause,

Julia Humphries,

Alberto Smith,

K G Burnand,

Marschall S. Runge

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.908319

Subject(s) - nadph oxidase , nox1 , vascular smooth muscle , activator (genetics) , p22phox , medicine , microbiology and biotechnology , protein kinase b , reactive oxygen species , signal transduction , pharmacology , biology , receptor , smooth muscle

Despite a concerted effort by many laboratories, the critical subunits that participate in vascular smooth muscle cell (VSMC) NADPH oxidase function have yet to be elucidated. Given the potential therapeutic importance of cell-specific inhibition of NADPH oxidase, we investigated the role of Nox activator 1 (NoxA1), a homolog of p67phox, in VSMC NADPH oxidase function and atherosclerosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research